Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Endometrial Neoplasms 2 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oligomenorrhea 1 Menstruation Disturbances 1 Kidney Neoplasms 1 Infertility 1 Hyperandrogenism 1 Hirsutism 1 Hip Fractures 1 Hepatic Veno-Occlusive Disease 1 HCC 1 Fibrosis 1 Fatigue 1 Endocrine System Diseases 1 Disease 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Anovulation 1

Interventions

Sunitinib 14 aldesleukin 10 Bevacizumab 8 pembrolizumab 7 Nivolumab 7 pazopanib 5 Axitinib 5 atezolizumab 4 Interferon-alpha 4 sintilimab 3 durvalumab 3 Sorafenib 3 Everolimus 3 Cyclophosphamide 3 Chemotherapy, Adjuvant 3 toripalimab 2 sargramostim 2 olaparib 2 lenvatinib 2 fludarabine phosphate 2 camrelizumab 2 avelumab 2 Neoadjuvant Therapy 2 Laparoscopy 2 Ipilimumab 2 Interferon alpha-2 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Gene Expression Profiling 2 Fluorouracil 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Renal Cell × Hematologic Tests × Clear all

NCT04113486 2020-11-24

ENRC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡